Clincosm LogoSign in Get a demo

colorectal cancer liver metastases

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Liver Metastases Trial in Shanghai (Cetuximab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • Shanghai, Shanghai, China
  • +1 more
May 22, 2023

Colorectal Cancer Liver Metastases, Regorafenib Trial in Guangdong (Regorafenib and DIBIRI, Regorafenib)

Recruiting
  • Colorectal Cancer Liver Metastases
  • Regorafenib
  • Guangdong, Guangzhou, China
    Bo Zhang
Mar 20, 2023

Colorectal Cancer Liver Metastases, Colorectal Cancer, Liver Metastases Trial in Denmark, Norway, Sweden (Acetylsalicylic acid,

Active, not recruiting
  • Colorectal Cancer Liver Metastases
  • +2 more
  • Acetylsalicylic acid
  • Placebo Oral Tablet
  • Aarhus, Denmark
  • +13 more
Oct 19, 2022

Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)

Not yet recruiting
  • Colorectal Cancer Liver Metastases
  • CapOx(Capecitabine+ Oxaliplatin)
  • +2 more
  • (no location specified)
Oct 18, 2022

Colorectal Cancer Liver Metastases Trial in Guangzhou (Radiofrequency ablation, Regorafenib and Toripalimab Combination)

Recruiting
  • Colorectal Cancer Liver Metastases
  • Radiofrequency ablation
  • Regorafenib and Toripalimab Combination
  • Guangzhou, Other (Non U.s.), China
    Zhiqiang Wang
Aug 2, 2022

Colorectal Cancer Liver Metastases Trial in New York ([18-F]- FDG - PET, Thermal ablation (TA), PET/CT Scan)

Recruiting
  • Colorectal Cancer Liver Metastases
  • [18-F]- FDG - PET
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 16, 2022

Colorectal Cancer Liver Metastases Trial in Milan (capecitabine, oxaliplatin, irinotecan and bevacizumab)

Completed
  • Colorectal Cancer Liver Metastases
  • capecitabine, oxaliplatin, irinotecan and bevacizumab
  • Milan, Mi, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Aug 6, 2019